PUBLISHER: Grand View Research | PRODUCT CODE: 1609628
PUBLISHER: Grand View Research | PRODUCT CODE: 1609628
The global fertility tourism market size is expected to reach USD 6.18 billion by 2030, exhibiting a CAGR of 25.11% from 2025 to 2030, according to a new report by Grand View Research, Inc. Lower cost of treatment in neighboring countries and a high success rate of IVF in countries such as Spain, U.S., and the U.K. are main factors due to which people are opting for reproductive tourism. Furthermore, the increasing rate of infertility due to factors such as high alcohol consumption, drug abuse, stress, and smoking is propelling the market.
Delayed pregnancy in women is favoring the market growth. Technological advancements and the introduction of IVF and various assisted reproductive technologies are likely to bode well with the market. Countries such as U.S., Spain, India, Czech Republic, are offering advanced treatments such as intracytoplasmic sperm injection, gamete intrafallopian transfer, Zygote intrafallopian transfer, and others. Many single women and gay or lesbian couples have to opt for reproductive tourism as the regulatory frameworks in their home counties do not allow them to avail treatments.
The COVID-19 pandemic adversely impacted the medical tourism industry. It shook the travel and tourism industry to its foundations. Prominent hospital service providers suffered heavy losses in 2020, as COVID-19 pandemic travel restrictions negatively affected medical services aimed at medical tourists. A sharp decline in the number of patient arrivals due to travel bans and strict regulations heavily impacted the fertility tourism industry.